Log in
Infectious Diseases · Viral Hepatitis and HIV

Hepatitis C

Hepatitis C

Hepatitis C (HCV) is a viral liver disease that requires mandatory differential diagnosis with other viral infections (HAV, HBV, HDV). Due to the similarity of the clinical presentation at various stages of the disease, establishing an accurate diagnosis requires relying not only on symptoms, but also on specific infection markers.

Differential diagnosisHCV is differentiated from hepatitis A, B, D, E, and toxic liver injury
Incubation periodIn viral liver diseases (e.g., HBV), it can reach up to 180 days
Key distinctionDiagnosis is established only after evaluating the specific serological profile
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Differential diagnosis and stages of the course

Since viral hepatitis often presents with a similar clinical picture, hepatitis C must be included in the differential diagnostic workup upon the appearance of hepatobiliary system involvement.

The classic cyclic course of acute viral liver disease (using typical hepatitis B as an example, which is most frequently used for comparison) is divided into four distinct stages:

  1. Incubation period.
  2. Pre-icteric (prodromal) period.
  3. Icteric period (peak of the disease).
  4. Convalescent period (recovery).

During the pre-icteric period, the disease often mimics other pathologies. Influenza-like, dyspeptic, or asthenovegetative onset variants are possible. Patients experience fatigue, nausea, pain in large joints (without signs of inflammation), and occasionally transient urticarial rash. At this stage, viral hepatitis must be differentiated from rheumatic fever and drug-induced disease. Key reference points include epidemiological history, hepatomegaly, and hyperfermentemia (elevated ALT and AST activity).

Icteric period: clinical and laboratory syndromes

Upon transition to the icteric stage, the patient's well-being generally does not improve (unlike in hepatitis A). To establish an accurate diagnosis and rule out other causes of jaundice (including hepatitis C, toxic injury, and mechanical obstruction), key syndromes are evaluated:

  • Intoxication syndrome: fatigue increases, appetite disappears, and sleep inversion may occur.
  • Abdominal syndrome: heaviness in the right upper quadrant, hepatomegaly (smooth liver edge), and splenomegaly in one-third of patients.
  • Cytolytic syndrome: a significant increase in transaminases (by tens of times).
  • Pigment metabolism disorder: persistent hyperbilirubinemia, scleral and cutaneous icterus, dark urine, and acholic stools.

In severe cases, hemorrhagic syndrome (gingival bleeding, epistaxis) and signs of hepatocellular insufficiency with encephalopathy may develop.

Test your knowledge on the topicTasks from the "Infectious Diseases" course bank — instant answers and analysis.

Specific markers and diagnostic algorithm

Clinical and biochemical data (cytolysis, indicator dissociation) are sufficient only to suspect viral hepatitis. A definitive (etiological) diagnosis requires identifying markers of a specific pathogen using ELISA and PCR.

During differential diagnosis, the physician must rule out the presence of hepatitis B markers, which are detailed in clinical practice:

  • HBsAg — an early antigen appearing as early as the incubation period;
  • HBeAg — an indicator of active viral replication;
  • Anti-HBc-IgM — evidence of the acute phase;
  • HBV-DNA — a marker of active replication.

The absence of these specific markers in the presence of viral hepatitis symptoms prompts the physician to specifically search for hepatitis C virus RNA and other etiological factors.

Outcomes and epidemiological control

The outcome of acute viral hepatitis depends on the pathogen type and severity of the course. If the process does not conclude with complete clinical and laboratory recovery, there is a risk of progression to a chronic form.

To prevent the spread of parenteral hepatitis (which includes hepatitis B and C), strict measures of non-specific prevention are applied:

  • Total screening of donor blood and organs.
  • Quarantine of blood products.
  • Strict infection control and instrument sterilization in medical facilities.
  • Promotion of barrier contraception methods and safe behavior.

Briefly: answers to topical questions

What specific serological and molecular markers are used to confirm acute hepatitis C?

To confirm acute hepatitis C, antibodies to the pathogen and the detection of its genetic material are used.

  • Total antibodies (anti-HCV total) — a serological marker; however, a negative result at the initial stage does not rule out the disease, as seroconversion may occur with a significant delay.
  • Viral RNA (HCV RNA) — a molecular marker that must be detected for final verification of the infection in the patient's blood.

What is the mechanism of hepatic encephalopathy development in severe forms of viral hepatitis?

The mechanism of hepatic encephalopathy development is described by the “glia hypothesis”: against the background of an amino acid imbalance, endogenous neurotoxins affect astroglia, causing its edema and impaired function.

  • Ammonia — a key neurotoxin; it accumulates due to the liver's loss of detoxifying function and the suppression of ammonia-binding processes. In its unionized form, it crosses the blood-brain barrier, decreases ATP synthesis, and stimulates the transport of aromatic amino acids into brain tissue.
  • False neurotransmitters ($eta$-phenylethanolamine, octopamine) are formed from an excess of aromatic amino acids, compete with receptors, and displace true mediators, leading to depression of the nervous system.
  • Serotonergic system: tryptophan accumulation causes an increase in serotonin levels and an increase in the number of 5-HT1 receptors, disrupting sleep-wake regulation, behavior, and level of consciousness.
  • GABAergic system: GABA concentration and the number of GABA receptors increase.

In 50–75% of cases, acute hepatic encephalopathy progresses to cerebral edema and swelling, which can lead to impaired cerebral hemodynamics and irreversible ischemia of brain structures.

Class and exam questions

Is a biochemical blood test sufficient to confirm the diagnosis?

No, biochemical shifts (cytolytic and cholestatic syndromes) only confirm the fact of liver damage. For an etiological diagnosis, PCR and ELISA for specific viral markers are required.

Something unclear? Ask the AIThe AI tutor has read the material on "Hepatitis C" and will explain it in simple terms.

What else to study on this topic

  • Clinical and diagnostic features of viral hepatitis B
  • Specific (vaccine) prevention of parenteral hepatitis
  • Decoding the serological profile: antigens and antibodies
  • Hepatocellular insufficiency syndrome and encephalopathy

Master the complete topic in the «Infectious Diseases» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Hepatitis C" and 3,312 more subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 41 video lessons on the subject

Other topics in the section "Viral Hepatitis and HIV"

The entire section "Viral Hepatitis and HIV"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.